EUVIMEDOpdag EUVIMED
Crossref

The Impact of Lovenox Prophylaxis and Other Anticoagulants on Microvascular Free Flap Outcomes

Kavita Bhatnagar iD, Hannah Smith, Farshid Taghizadeh, Gavin Young, Skylar Trott, Daniel Clayburgh, Sara Yang, Mark K Wax

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1160 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Kavita Bhatnagar and 7 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA. Major MEDLINE topics: Free Tissue Flaps, Anticoagulants, Postoperative Complications, Plastic Surgery Procedures. Cited 2 times so far (Crossref); 23 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Microvascular free flap reconstruction for head and neck defects carries a 95% success rate. When flap compromise occurs, it is often due to vascular occlusion. This study seeks to determine what impact lovenox prophylaxis has on flap outcomes and postoperative complications. Study Design A retrospective review.

Setting

A single tertiary institution.

Methods

A total of 1100 patients underwent microvascular free flap reconstruction from January 2010 to May 2019. The use of lovenox prophylaxis began in 2013, and by 2015, it was routinely used. Flap outcome and postoperative complications were compared between those who received postoperative lovenox prophylaxis and those who did not, using a chi‐squared analysis. Outcomes among patients on therapeutic heparin and other oral anticoagulants were similarly examined.

Results

There was no difference between those with (n = 716) or without chemoprophylaxis (n = 384) in rates of flap compromise (11.46% vs 12.71%), salvage (43.19% vs 52.71%), and overall failure (6.51% vs 6.01%) ( P = .45). Rates of arterial insufficiency (8.07% vs 7.82%, P = .89) and venous congestion (3.39% vs 5.73%, P = .09) were equivalent. Arterial insufficiency (23.85%, P = .0002) was highest among the therapeutic heparin group. The rate of hematoma was significantly different between those without chemoprophylaxis (2.08%), and those on lovenox (3.77%), heparin (10.55%), and other anticoagulants (14.55%) ( P = 4 × 10 −8 ).

Conclusions

Lovenox prophylaxis does not appear to impact overall flap survival but does confer a small increase in hematoma risk. There were higher rates of complications among patients on therapeutic heparin. Patients who require anticoagulation for other medical comorbidities are nearly 4 times as likely to develop hematomas and should be counseled accordingly.

Subjects

MeSH terms (MEDLINE)

Free Tissue FlapsAnticoagulantsPostoperative ComplicationsPlastic Surgery ProceduresEnoxaparinHead and Neck NeoplasmsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTreatment OutcomeHeparinAdult

Author keywords

anticoagulationfree flaplovenoxoutcomesprophylaxis

Substances

AnticoagulantsEnoxaparinHeparin

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA.
  • Oregon Health and Science University School of Medicine, Portland, Oregon, USA.

ORCID profiles: Kavita Bhatnagar

Cite

APA

Bhatnagar, K., Smith, H., Taghizadeh, F., Young, G., Trott, S., Clayburgh, D., Yang, S., & Wax, M. K. (2025). The Impact of Lovenox Prophylaxis and Other Anticoagulants on Microvascular Free Flap Outcomes. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1160

Vancouver

Bhatnagar K, Smith H, Taghizadeh F, Young G, Trott S, Clayburgh D, et al. The Impact of Lovenox Prophylaxis and Other Anticoagulants on Microvascular Free Flap Outcomes. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1160

BibTeX
@article{Bhatnagar2025,
  author = {Bhatnagar, Kavita and Smith, Hannah and Taghizadeh, Farshid and Young, Gavin and Trott, Skylar and Clayburgh, Daniel and Yang, Sara and Wax, Mark K},
  title = {The Impact of Lovenox Prophylaxis and Other Anticoagulants on Microvascular Free Flap Outcomes},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1160}
}
Start for free →